BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-0.04%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$147M
AUM Growth
+$147M
(-3.1%)
Cap. Flow
-$1.68M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
83.52%
Holding
56
New
7
Increased
6
Reduced
13
Closed
3
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$850K |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$654K |
| 3 |
InflaRx
IFRX
|
$516K |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$497K |
| 5 |
Nektar Therapeutics
NKTR
|
$464K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.83M |
| 2 |
BIOL
Biolase, Inc.
BIOL
|
$1.39M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$631K |
| 4 |
Solid Biosciences
SLDB
|
$499K |
| 5 |
SHPG
Shire pic
SHPG
|
$403K |
Sector Composition
| 1 | Healthcare | 95.63% |
| 2 | Energy | 3.26% |
| 3 | Consumer Staples | 0.26% |
| 4 | Industrials | 0.25% |
| 5 | Consumer Discretionary | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $54.5M | 37.04% | 686,181 -23,000 | -3% | -$1.83M |
|
|
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
| $48.7M | 33.1% | 2,183,795 | – | – |
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $4.91M | 3.34% | 50,000 -2,400 | -5% | -$236K |
|
|
CFRX
4
DELISTED
ContraFect Corporation
CFRX
| $2.38M | 1.61% | 1,075,082 -60,000 | -5% | -$133K |
|
5
QuidelOrtho
QDEL
$1.95B
| $2.26M | 1.54% | 33,975 | – | – |
|
|
ARRY
6
DELISTED
Array Biopharma Inc
ARRY
| $2.15M | 1.46% | 128,000 +16,000 | +14% | +$269K |
|
7
Ovintiv
OVV
$10.8B
| $2.12M | 1.44% | 162,300 +30,000 | +23% | +$391K |
|
8
EQT Corp
EQT
$32.4B
| $2.11M | 1.44% | 38,300 -4,000 | -9% | -$221K |
|
|
OXFD
9
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.03M | 1.38% | 157,303 -20,000 | -11% | -$258K |
|
|
VRML
10
DELISTED
Vermillion, Inc.
VRML
| $1.74M | 1.18% | 2,232,933 -130,000 | -6% | -$101K |
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $1.68M | 1.14% | 88,000 | – | – |
|
12
Soleno Therapeutics
SLNO
$3.6B
| $1.59M | 1.08% | 678,428 | – | – |
|
|
ALBO
13
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $1.35M | 0.92% | 38,000 +14,000 | +58% | +$497K |
|
14
Atara Biotherapeutics
ATRA
$84.6M
| $1.25M | 0.85% | 34,000 +11,000 | +48% | +$404K |
|
|
SIEN
15
DELISTED
Sientra, Inc.
SIEN
| $1.24M | 0.84% | 63,300 | – | – |
|
|
ARNA
16
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.09M | 0.74% | 25,000 +15,000 | +150% | +$654K |
|
|
GTHX
17
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $956K | 0.65% | 22,000 | – | – |
|
18
Veracyte
VCYT
$2.39B
| $922K | 0.63% | 98,767 -20,000 | -17% | -$187K |
|
|
CMTA
19
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $895K | 0.61% | 68,000 +30,000 | +79% | +$395K |
|
|
20
Karyopharm Therapeutics
KPTI
$61.7M
| $850K | 0.58% | +50,000 | New | +$850K |
|
21
Corcept Therapeutics
CORT
$7.35B
| $786K | 0.53% | 50,000 -25,500 | -34% | -$401K |
|
22
Masimo
MASI
$7.59B
| $781K | 0.53% | 8,000 | – | – |
|
|
WMGI
23
DELISTED
Wright Medical Group Inc
WMGI
| $779K | 0.53% | 30,000 | – | – |
|
24
Voyager Therapeutics
VYGR
$186M
| $645K | 0.44% | 33,000 | – | – |
|
25
Axogen
AXGN
$743M
| $603K | 0.41% | 12,000 -6,000 | -33% | -$302K |
|